We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.
Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


Image: QIAGEN has acquired OmicSoft, a bioinformatics company (Photo courtesy of iStock).

Qiagen Acquires Bioinformatics Firm OmicSoft

QIAGEN N.V., a provider of sample and assay technologies, has acquired OmicSoft Corporation, which focuses on biomarker data management, visualization, and analysis. More...
12 Jan 2017

Global Digital Pathology Market Worth USD 1,052 Million by 2022

The global digital pathology market will reach USD 1,052 million by 2022, driven by the growing popularity of virtual slides over physical slides, technological advancements, and cost-effective products, with North America accounting for the major share. More...
25 Jul 2016

Collaborative Agreement to Aid in Setting Guidelines for Evaluating Potential Ebola Therapy

Cooperation between an Israeli biopharmaceutical company and medical branches of the US government is designed to set ground rules for continued evaluation of an experimental therapy for Ebola virus disease. More...
25 Jul 2016

Sartorius Acquires US Start-up ViroCyt

Sartorius AG (Göttingen, Germany), a pharmaceutical and laboratory equipment provider, has acquired ViroCyt Incorporated (Broomfield, CO, USA), a start-up in the field of rapid virus quantification, in a deal valued at approximately USD 16 million. More...
22 Jul 2016

Biotech Investment to Boost Chinese Pharmaceutical Manufacturing Capability

An American biopharmaceutical company will be contributing to the development of a state-of-the-art global biotechnology center in Hangzhou, China, to promote the production of biosimilar medicines for local use and for export. More...
11 Jul 2016

Agreement to Boost Development of Novel RNA-Based Personalized Cancer Vaccines

A strategic collaboration and license agreement is set to boost the development and commercialization of novel messenger RNA (mRNA)-based personalized cancer vaccines. More...
11 Jul 2016

Drug Development Based on Genome Editing Technology Receives Funding Boost

An American biopharmaceutical company dedicated to translating CRISPR/Cas9 gene-editing technology into transformative medicines announced the successful conclusion of Series B fund raising activities. More...
05 Jul 2016

BioResearch Industry News channel updates the reader on mergers and takeovers, on cooperative agreements and on trends in the biotech industry worldwide.
Copyright © 2000-2019 Globetech Media. All rights reserved.